Iovance Biotherapeutics, Inc. Share Price

Iovance Biotherapeutics, Inc. Share Price

NASDAQ: IOVA | Micro Cap
$8.47
-$1.09 (-11.45%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Iovance Biotherapeutics, Inc. Stock Performance

Open
$9.13
Prev. Close
$9.56
Circuit Range
N/A
Day Range
$8.27 - $9.15
Year Range
$1.76 - $15.35
Volume
17,78,247
Average Traded
$8.55

Iovance Biotherapeutics, Inc. Share Price Today

As of 31 October 2026, Iovance Biotherapeutics, Inc.'s share price is $8.47. The stock opened at $9.13, compared to its previous close of $9.56. During today's trading session, Iovance Biotherapeutics, Inc.'s share price traded between $8.27 and $9.15, with an average price of $8.71. Over the past 52 weeks, the stock has recorded a high of $15.35 and a low of $1.76. In terms of performance, Iovance Biotherapeutics, Inc.'s share price has risen by 152.84% over the last six months and is up 332.14% on a year-on-year basis.

Iovance Biotherapeutics, Inc. Share Price Chart

Line chart of the Iovance Biotherapeutics, Inc. price trend over the selected period. The price fell overall, ranging from 8.29 to 9.03, ending at 8.47.
$8.27$9.15
L
Show Current Price
H

Iovance Biotherapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.03M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.64
Revenue (TTM)
$263.50B
Return On Equity (TTM)
-39.33%
Profit Margin
-148.38%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
48.14%

Iovance Biotherapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$67.46$86.77$71.43$99.31
Net Profit-$91.25-$71.90-$79.05-$47.32
Net Profit Margin-135.27%-82.86%-110.67%-47.65%
Income ChangeN/A21.21%-9.94%40.14%

Iovance Biotherapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$1.19$164.07$263.50
Net Profit-$395.89-$444.04-$372.18-$390.98
Net Profit MarginN/A-37314.29%-226.84%-148.38%
Income ChangeN/A-12.16%16.18%-5.05%

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Iovance Biotherapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$14.76
$8.44
-43.08%
Sep 2026
$8.02
$14.82
+79.20%
Aug 2026
$4.11
$8.27
+103.74%
Jul 2026
$4.17
$4.06
-2.43%
Jun 2026
$4.15
$4.16
+1.46%
May 2026
$3.37
$4.10
+22.39%
Apr 2026
$3.60
$3.35
-4.56%
Mar 2026
$3.67
$3.51
-9.54%
Feb 2026
$2.53
$3.88
+52.76%
Jan 2026
$2.78
$2.54
-6.96%
Dec 2025
$2.40
$2.73
+10.75%
Nov 2025
$2.15
$2.46
+25.77%

IOVA Share Price FAQs